Trial Profile

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Empagliflozin (Primary) ; Sitagliptin (Primary)
Indications Diabetes mellitus
Focus Pharmacodynamics
Acronyms Px-Meal

Most Recent Events

25 Sep 2020 Results assessing effects of the empagliflozin on fasting and postprandial glucose concentrations in PX patients and matched healthy controls, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association
02 Sep 2019 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com